Tonix Pharmaceuticals Holding Corp, Inc. 8-K
Exhibit 23.01
 |
| KPMG LLP 4200 Wells Fargo Center |
Consent of Independent Auditors
We consent to the incorporation by reference in the registration statements (Nos. 333-237610, 333-251500, 333-254975, and 333-266982) on Form S-3 and registration statements (Nos. 333-202006, 333-212300, 333-219928, 333-226776, 333-232137, 333-239152, 333-257437, 333-265705 and 333-272746) on Form S-8 of Tonix Pharmaceuticals Holding Corp. of our report dated July 18, 2023, with respect to the abbreviated financial statements of the Tosymra ® and Zembrace ® Symtouch ® Product Lines of Upsher-Smith Laboratories LLC, which report appears in the Form 8-K/A of Tonix Pharmaceuticals Holding Corp. dated July 18, 2023.
Minneapolis, Minnesota
July 18, 2023